Kyushu University Academic Staff Educational and Research Activities Database
List of Papers
Mitsuho Onimaru Last modified date:2021.06.19

Assistant Professor / Pathobiology / Department of Basic Medicine / Faculty of Medical Sciences


Papers
1. Isobe M, Amano K, Arimura Y, Ishizu A, Ito S, Kaname S, Kobayashi S, Komagata Y, Komuro I, Komori K, Takahashi K, Tanemoto K, Hasegawa H, Harigai M, Fujimoto S, Miyazaki T, Miyata T, Yamada H, Yoshida A, Wada T, Inoue Y, Uchida HA, Ota H, Okazaki T, Onimaru M, Kawakami T, Kinouchi R, Kurata A, Kosuge H, Sada KE, Shigematsu K, Suematsu E, Sueyoshi E, Sugihara T, Sugiyama H, Takeno M, Tamura N, Tsutsumino M, Dobashi H, Nakaoka Y, Nagasaka K, Maejima Y, Yoshifuji H, Watanabe Y, Ozaki S, Kimura T, Shigematsu H, Yamauchi-Takihara K, Murohara T, Momomura SI., JCS 2017 Guideline on Management of Vasculitis Syndrome - Digest Version. JCS Joint Working Group., Circ J., 84(2): 299-359., 2020.01.
2. Daitoku S, Onimaru M, Tanimoto K, Kuroiwa M., Atraumatic splenic ruptures triggered both remission and death in a single case of blastic plasmacytoid dendritic cell neoplasm., J Clin Exp Hematop., 59, 1, 40-45, 59(1):40-45., 2019.03.
3. Kasagi Y, Harada Y, Morodomi Y, Iwai T, Saito S, Yoshida K, Oki E, Saeki H, Ohgaki K, Sugiyama M, Onimaru M, Maehara Y, Yonemitsu Y., Peritoneal Dissemination Requires an Sp1-Dependent CXCR4/CXCL12 Signaling Axis and Extracellular Matrix-Directed Spheroid Formation., Cancer Res., 10.1158/0008-5472.CAN-15-1563, 76, 2, 347-357, 2016.01.
4. Kyuragi R, Matsumoto Takuya, Harada Y, Saito S, Onimaru M, Nakatsu Y, Tsuzuki T, Nomura M, Yonemitsu Y, Maehara Y, BubR1 insufficiency inhibits neointimal hyperplasia through impaired vascular smooth muscle cell proliferation in mice., Arterioscler Thromb Vasc Biol. , 35, 2, 341-347, 2015.02.
5. Kanno S, Nishio H, Tanaka T, Motomura Y, Murata K, Onimaru M, Yamasaki S, Kono H, Sueishi K, Hara T, Activation of an innate immune receptor, Nod1, accelerates atherogenesis in Apoe-/- mice., 194, 2, 773-780, 2015.01.
6. Saito S, Harada Y, Yoshida K, Morodomi Y, Onimaru M, Kyuragi R, Matsubara H, Yonemitsu Y, Ex vivo generation of highly purified and activated natural killer cells from human peripheral blood., Hum Gene Ther Methods., 24, 4, 241-252, 2013.08.
7. Ishibashi H, Nariai Y, Kanno T, Mitsuho Onimaru, Sekine J, Effects of transforming growth factor beta 1 on the plasminogen activation system, collagen and integrin synthesis, and proliferation of rabbit mandibular condylar chondrocytes., Int J Oral Maxillofac Surg, 43, 4, 470-475, 2014.04.
8. Fujinaga T, Kumamaru W, Sugiura T, Kobayashi Y, OHYAMA Y, Ikari T, Onimaru M, Akimoto N, Jogo R, Mori Y, Biological characterization and analysis of metastasis-related genes in cell lines derived from the primary lesion and lymph node metastasis of a squamous cell carcinoma arising in the mandibular gingiva., Int J Oral, 44, 5, 1614-1624, 2014.05.
9. Imai M, Ishibashi H, Nariai Y, Kanno T, Sekine J, Onimaru M, Mori Y., Transfection of hypoxia-inducible factor-1 decoy oligodeoxynucleotides suppresses expression of vascular endothelial growth factor in oral squamous cell carcinoma cells., ournal of oral pathology & medicine, 2012.05.
10. Suzuki H, Onimaru M, Koga T, Takeshita M, Yano T, Maehara Y, Nakamura S, Sueishi K., High podoplanin expression in cancer cells predicts lower incidence of nodal metastasis in patients with lung squamous cell carcinoma., Pathol Res Pract. , 207(2):111-5, 2011.02.
11. Sugiyama M, Kakeji Y, Tsujitani S, Harada Y, Onimaru M, Yoshida K, Tanaka S, Emi Y, Morita M, Morodomi Y, Hasegawa M, Maehara Y, Yonemitsu Y., Antagonism of VEGF by genetically engineered dendritic cells is essential to induce antitumor immunity against malignant ascites., Mol Cancer Ther. , 10(3):540-9, 2011.01.
12. Suzuki H, Onimaru M, Yonemitsu Y, Maehara Y, Nakamura S and Sueishi K, Podoplanin in cancer cells is experimentally able to attenuate prolymphangiogenic and lymphogenous metastatic potentials of lung squamoid cancer cells, Molecular Cancer , 2010, 9:287 (31 October 2010), 2010.11.
13. Hasegawa Y, Kinoh H, Iwadate Y, Onimaru M, Ueda Y, Harada Y, Saito S, Furuya A, Saegusa T, Morodomi Y, Hasegawa M, Saito S, Aoki I, Saeki N, Yonemitsu Y., Urokinase-targeted fusion by oncolytic Sendai virus eradicates orthotopic glioblastomas by pronounced synergy with interferon-β gene., Mol Ther, 2010 Oct;18(10):1778-86, 2010.10.
14. Onimaru M, Yonemitsu Y, Suzuki H, Fujii T, Sueishi K, An Autocrine Linkage Between Matrix Metalloproteinase-14 and Tie-2 via Ectodomain Shedding Modulates Angiopoietin-1-Dependent Function in Endothelial cells, Arteriosclerosis, Thrombosis, and Vascular Biology, 30, 818-826, 2010.04.
15. Matsuura M, Onimaru M, Yonemitsu Y, Suzuki H, Nakano T, Ishibashi H, Shirasuna K, Sueishi K, Autocrine loop between vascular endothelial growth factor (VEGF)-C and VEGF receptor-3 positively regulates tumor-associated lymphangiogenesis in oral squamoid cancer cells, Am J Pathol. , 2009 Oct;175(4):1709-21. , 2009.10.
16. Fujii T, Yonemitsu Y, Onimaru M, Inoue M, Hasegawa M, Kuwano H, Sueishi K., VEGF function for upregulation of endogenous PlGF expression during FGF-2-mediated therapeutic angiogenesis., Atheroscrelosis, 200(1):51-7., 2008.02.
17. Murakami Y, Ikeda Y, Yonemitsu Y, Onimaru M, Nakagawa K, Kohno R, Miyazaki M, Hisatomi T, Nakamura M, Yabe T, Hasegawa M, Ishibashi T, Sueishi K., Inhibition of nuclear translocation of apoptosis-inducing factor is an essential mechanism of the neuroprotective activity of pigment epithelium-derived factor in a rat model of retinal degeneration, American Journal of Pathology, 173(5):1326-38., 2008.11.
18. Kaneko K, Yonemitsu Y, Fujii T, Onimaru M, Jin CH, Inoue M, Hasegawa M, Onohara T, Maehara Y, Sueishi K., A free radical scavenger but not FGF-2-mediated angiogenic therapy rescues myonephropathic metabolic syndrome in severe hindlimb ischemia.  , American Journal of Physiology, 290(4):H1484-92. , 2006.04.
19. Tanii M, Yonemitsu Y, Fujii T, Shikada Y, Kohno R, Onimaru M, Okano S, Inoue M, Hasegawa M, Onohara T, Maehara Y, Sueishi K. , Diabetic microangiopathy in ischemic limb is a disease of disturbance of the platelet-derived growth factor-BB/protein kinase C axis but not of impaired expression of angiogenic factors.  , Circulation Research, 98(1): 55-62. , 2006.01.
20. Shibata S, Okano S, Yonemitsu Y, Onimaru M, Sata S, Nagata-Takeshita H, Inoue M, Zhu T, Hasegawa M, Moroi Y, Furue M, Sueishi K. , Induction of Efficient Antitumor Immunity Using Dendritic Cells Activated by Recombinant Sendai Virus and Its Modulation by Exogenous IFN-beta Gene., Journal of Immunology, 177(6):3564-76. , 2006.07.
21. Ikeda Y, Yonemitsu Y, Onimaru M, Nakano T, Miyazaki M, Kohno RI, Nakagawa K, Ueno A, Sueishi K, Ishibashi T. , The regulation of vascular endothelial growth factors (VEGF-A, -C, and -D) expression in the retinal pigment epithelium. , Experimental Eye Ressearch, 83(5): 1031-1040. , 2006.11.
22. Fujii T, Yonemitsu Y, Onimaru M, Tanii M, Nakano T, Egashira K, Takehara T, Inoue M, Hasegawa M, Kuwano H, Sueishi K., Nonendothelial Mesenchymal Cell-Derived MCP-1 Is Required for FGF-2-Mediated Therapeutic Neovascularization. Critical Role of the Inflammatory/Arteriogenic Pathway., Arterioscler Thromb Vasc Biol., 2006.10.
23. Shikada Y, Yonemitsu Y, Koga T, Onimaru M, Nakano T, Okano S, Sata S, Nakagawa K, Yoshino I, Maehara Y, Sueishi K. , Platelet-derived growth factor-AA is an essential and autocrine regulator of vascular endothelial growth factor expression in non-small cell lung carcinomas.  , Cancer Res. , 10.1158/0008-5472.CAN-04-4171, 65, 16, 7241-7248, 65(16): 7241-8. , 2005.10.
24. Baba H, Yonemitsu Y, Nakano T, Onimaru M, Miyazaki M, Ikeda Y, Sumiyoshi S, Ueda Y, Hasegawa M, Yoshino I, Maehara Y, Sueishi K. , Cytoplasmic expression and extracellular deposition of an antiangiogenic factor, pigment epithelium-derived factor, in human atherosclerotic plaques. , Arterioscler Thromb Vasc Biol. , 10.1161/01.ATV.0000175759.78338.1e, 25, 9, 1938-1944, 25(9):1938-44. , 2005.10.
25. Tsutsumi N, Yonemitsu Y, Shikada Y, Onimaru M, Tanii M, Okano S, Kaneko K, Hasegawa M, Hashizume M, Maehara Y, Sueishi K.  , Essential role of PDGFRalpha -p70S6Ksignaling in mesenchymal cells during therapeutic and tumor angiogenesis in vivo: role of PDGFR during angiogenesis.  , Circ Res. , 10.1161/01.RES.0000126925.66005.39, 94, 9, 1186-1194, 94(9): 1186-94. , 2004.10.
26. Ishibashi H, Shiratuchi T, Nakagawa K, Onimaru M, Sugiura T, Sueishi K, Shirasuna K., Hypoxia-induced angiogenesis of cultured human salivary gland carcinoma cells enhances vascular endothelial growth factor production and basic fibroblast growth factor release. , Oral Oncol. , 10.1016/S1368-8375(00)00062-2, 37, 1, 77-83, 37; 77-83, 2001.01.
27. Ishibashi H, Nakagawa K, Onimaru M, Castellanous EJ, Kaneda Y, Nakashima Y, Shirasuna K, Sueishi K., Sp1 decoy transfected to carcinoma cells suppresses the expression of vascular endothelial growth factor, transforming growth factor beta1, and tissue factor and also cell growth and invasion activities. , Cancer Res. , 60, 22, 6531-6536, 60(22);6531-6, 2000, 2000.02.